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Abstract
Recent research has established the detrimental effect of lorazepam, a benzodiazepine, on both implicit and explicit memory.
Furthermore, lorazepam is known to affect perceptual integration. Diazepam, on the other hand, though being a benzodiazepine
too, only impairs explicit memory, leaving implicit memory fairly intact. Little is known about the effect of diazepam on
perceptual integration. The present study aimed at filling in this gap, by comparing the effects of lorazepam and diazepam on the
detection of discontinuities in random-shaped outlines. In line with previous findings, the results in a lorazepam-treated group
were quite different from the results in a placebo-treated group. The results in a diazepam-treated group were analogous to the
results in the placebo-treated group and different from the results in the lorazepam-treated group. This shows that lorazepam and
diazepam differ, not only with respect to their effect on implicit memory, but also with respect to their effect on perceptual
integration. It is argued that this bears important consequences for memory research that makes use of a pharmacological
dissociation rationale. © 2001 Elsevier Science Ltd. All rights reserved.
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1. Introduction
A large amount of research has demonstrated that
benzodiazepines can be used to dissociate two forms of
memory. At doses with comparable potency, lorazepam
impairs both implicit and explicit memory, whereas
diazepam impairs only explicit memory, leaving implicit
memory fairly intact (for an overview, see Danion,
1994). In recent years, lorazepam has also proven to be
a valuable tool to investigate certain perceptual pro-
cesses, as it has been shown to impair the integration of
contour elements through low-level filling-in (see Gier-
sch, 1999, for a review). Little is known about the
influence of other benzodiazepines, like diazepam, on
this perceptual filling-in process.
There is some indirect evidence suggesting that di-
azepam too would impair filling-in. For one thing, the
mechanism underlying this impairment is most proba-
bly GABA-mediated and all benzodiazepines are, up
until now, believed to interact with the benzodiazepine/
GABAA receptor in fairly the same way (Paul, 1995).
Furthermore, in a study by Sellal et al. (1992), both
lorazepam and diazepam seemed to hamper the identifi-
cation of newly presented fragmented line drawings,
compared to placebo, though the impairment was sig-
nificant for neither drug (this study, together with a
study by Vidailhet et al. (1994); see below) was actually
the first indication of an influence of benzodiazepines
on perceptual integration).
Other evidence suggests that the lorazepam-induced
impairment in perceptual integration is not shared by
other benzodiazepines, e.g. diazepam. A theoretical ar-
gument would be that a GABA-dependent mechanism
does not preclude differential effects of various benzo-
diazepines. For example, the impairment of implicit
memory under lorazepam, though not shared by di-
azepam, seems to be GABA-mediated. Indeed, subse-
quent administration of a GABAA-antagonist greatly
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decreases the impairment of implicit memory, as mea-
sured using a priming task, following the intake of
lorazepam (Bishop & Curran, 1995). Secondly, in the
aforementioned study of Vidailhet et al. (1994), identifi-
cation of newly presented fragmented pictures was sig-
nificantly impaired by lorazepam, but not by diazepam.
To the best of our knowledge, all further research on
the influence of benzodiazepines on perceptual integra-
tion has been focused on lorazepam; no systematic
research has examined the effects of diazepam on per-
ceptual integration. The issue is important though, as
impairment of low-level perceptual integration pro-
cesses could, in some cases, be an alternative account
for effects in experimental psychopharmacology that
are currently ascribed to a pharmacologically-induced
impairment in implicit memory. Our claim is thus, that
in order to successfully apply the method of pharmaco-
logical dissociation to the study of the role of memory
processes in cognitive functioning, one should know the
effects of the pharmaca used on other cognitive pro-
cesses, for instance, perception. This claim holds even
more, since most studies examining memory deficits
following benzodiazepine administration make use of
perceptual priming tasks (Danion, Zimmerman,
Willard-Schroeder, Grange´, & Singer, 1989; Legrand et
al. 1995; Sellal et al., 1992; Vidailhet et al., 1994;
Vidailhet, Kaze`s, Danion, Kauffmann-Muller, &
Grange´, 1996) or other perceptual tasks (Wagemans,
Notebaert, & Boucart, 1998) to evaluate implicit mem-
ory functioning. An impairment in visual functioning
might thus lead to poor performance on such a task,
even if memory functioning is intact. Therefore, in
order to be able to use such tasks for the evaluation of
benzodiazepine influences on memory functioning, it is
extremely important to decide on the issue of whether
or not diazepam induces an impairment in perceptual
integration, as does lorazepam.
The present study was designed to shed some light on
this issue. To this end, we adapted a design previously
used by Lamote and Wagemans (1999). In their study,
meaningless smoothly curved outlines were briefly pre-
sented, immediately followed by a masking stimulus.
Half of the outlines were shown with full contour, the
other half contained contour deletions (41 pixels re-
moved) at three inflections (points of transition between
contour convexity and contour concavity, where curva-
ture is zero), at three loci of large contour convexity
(where curvature is at a local positive maximum) or at
three loci of large contour concavity (where curvature is
at a local negative minimum). Participants were simply
asked to judge whether or not the outlines shown had a
fully closed contour. The results showed that deletions
around inflections and deletions around negative min-
ima were difficult to detect, relative to the detection of
deletions around positive maxima. The rather poor
detection of deletions around negative minima may be
attributed to the fact that such gaps induce a segmenta-
tion of the contour in its natural parts (Hoffman &
Richards, 1984). For the relatively poor detection of
inflection gaps, automatic filling-in may be held respon-
sible: Boundary completion through filling-in occurs
due to interpolation between collinear line-segments
(Kellman & Shipley, 1991; Kova´cs & Julesz, 1993; for a
more general overview of perceptual filling-in phenom-
ena, see Pessoa, Thompson, & Noe¨, 1998) and is, as
such, much more pronounced at inflection gaps than at
minima or maxima gaps (compare Fig. 1(d) with Fig.
1(b,c)). We adapted the experiment and ran it under
pharmacological conditions (lorazepam, diazepam,
placebo). We predicted that the pattern of results for
the placebo group would mirror the pattern found by
Lamote and Wagemans (1999), i.e. deletions at inflec-
tions and deletions at negative minima harder to detect
than deletions at positive maxima. For the lorazepam
group, a relatively better detection of inflection dele-
tions compared to the placebo group was expected, due
to a disruption of perceptual filling-in. The crucial
comparison would be the comparison between the pat-
tern of results for the diazepam group and the pattern
of results for the other two groups. If the pattern of
results for the diazepam group mirrored the pattern for
the lorazepam group, then this would indicate that
diazepam disrupts filling-in, much the same way as
lorazepam. If the pattern of results for the diazepam
group was similar to the pattern for the placebo group,
then this would point to the disruption of perceptual
filling-in being specific for lorazepam (or a yet to be
defined subgroup of benzodiazepines).
Fig. 1. An example of the stimuli used in the experiment ((a) full
contour version; (b) version with gaps at three negative minima; (c)
version with gaps at three positive maxima; (d) version with gaps at
three inflections; all gaps 41 pixels).
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2. Material and methods
2.1. Subjects
The study was approved by the ‘Comite´ Consultatif
de Protection des Personnes dans la Recherche Biome´d-
icale d’Alsace I — Strasbourg’. Thirty paid (1000 FF)
healthy volunteers of both sexes (12 male, 18 female),
18–35 years of age, were recruited from the Faculty of
Medicine at the University of Strasbourg. They had no
medical illness or history of alcoholism, drug abuse or
tobacco consumption of more than ten cigarettes per
day. They were no chronic users of benzodiazepines
and none had taken any concomitant medication for at
least 21 days. Subjects were instructed to abstain from
beverages containing caffeine or alcohol for the 24 h
prior to the study. All subjects were tested in the
morning after an overnight fast. They all had normal or
corrected-to-normal vision. Written informed consent
was obtained from all volunteers before they entered
the study.
2.2. Stimuli
Stimuli were adapted from the set of smoothly
curved outlines of Lamote and Wagemans (1999). The
original set was created using a program that, accord-
ing to the method of Akima (1970), generates the
curves based on a few self-chosen dots. The software
also calculates curvature in each point on the contour
and indicates curvature singularities (negative minima,
positive maxima and inflections). Stimuli had to meet
certain criteria: reasonable amount of contour varia-
tion, balanced distribution of positive and negative
curvature and reasonable distance between curvature
singularities. Forty stimuli were created meeting these
criteria. Twelve versions of all stimuli were created:
four minima-deleted, four maxima-deleted and four
inflection-deleted versions. To this end, 41, 31, 21 or 11
pixels were removed around each of three curvature
singularities. For the maxima and the minima versions,
the three points with the highest absolute curvature
were removed, together with 20, 15, 10 or 5 points to
the left and to the right. For the inflection versions, the
three inflections for which the lowest absolute curvature
of the two neighboring extrema was maximal, together
with the surrounding pixels, were removed (see Fig. 1).
2.3. Experimental procedure and drugs
Subjects were randomly assigned to one of three
parallel groups of ten subjects each: a placebo (lactose
190 mg) group, a lorazepam 0.038 mg/kg group and a
diazepam 0.3 mg/kg group. Because our main interest
was in the effect of both drugs on perceptual integra-
tion at those doses ordinarily used to pharmacologi-
cally dissociate implicit and explicit memory, drug
doses were chosen accordingly. At these doses, both
drugs can furthermore be considered to be equally
potent, as evidenced by the equivalence of their effects
on sedation and on explicit memory (Dundee,
McGowan, Lilburn, McKay, & Hegarty, 1979;
Kothary, Brown, Pandit, Samra, & Pandit, 1981; Sellal
et al., 1992; Vidailhet et al., 1994). Drugs were adminis-
tered orally using a double-blind procedure. In order to
evaluate the effects of each drug at its peak plasma
concentration, which is usually attained within 60 min
after oral administration for diazepam and within 120
min for lorazepam (Greenblatt, Scavone, Harmatz, En-
gelhardt, & Shader, 1993; Mandelli, Tognoni, & Garat-
tini, 1978), a double-placebo procedure was used.
Subjects in the diazepam group received placebo at
07:30 h and diazepam at 08:30 h; subjects in the lo-
razepam group received lorazepam at 07:30 h and
placebo at 08:30 h; subjects in the placebo group re-
ceived placebo at both times.
The day before the actual experiment would take
place, subjects performed training sessions in order to
individually adapt the overall level of difficulty of the
task. The individual adaptation was implemented to
ensure a moderate performance level for all subjects, as
significant detection differences (measured using d s)
between the various deletion conditions can only be
found if the task is neither too easy nor too difficult
overall. This manipulation, necessary as it was, limits
the inferences that can be validly made from the results;
we will elaborate on this in the discussion. On the test
day, the training was repeated before starting the actual
experiment, as the benzodiazepines could provoke seda-
tion that would lower overall performance. Two sub-
jects were tested per day, the first starting at 09:00 h,
the second starting at 10:20 h; the experiment was part
of a series of experiments on visual perception and
visual attention.
2.4. Experimental design
Training sessions consisted of 78 trials presented in
random order. Each of 39 stimuli was presented once in
its non-deleted version and once in one of three possi-
ble deleted versions (13 in minima-deleted, 13 in max-
ima-deleted and 13 in inflection-deleted version).1 Each
trial started with a fixation point that was presented at
screen centre for 500 ms. After a 250 ms interval, the
target stimulus was presented for a multiple of 17.7 ms.
The target was immediately followed by a masking
stimulus (consisting of 200 circles with random position
and radius) that stayed on screen for 250 ms. Subjects
1 One of the stimuli was not used in the training sessions. This
stimulus was selected randomly and was the same for all participants
and training sessions.
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were simply asked to indicate whether they thought the
presented outline to be continuous or not, by pressing
the zero key (discontinuous contour) or the space bar
(continuous contour). Fixation point, target and mask
were presented as white stimuli on a black background.
At the end of each session, feedback was provided in
the form of an overall percentage of correct responses.
This feedback was used to adapt the difficulty of the
task. Task difficulty could be adapted by adjusting the
gap size (41, 31, 21, or 11 pixels per gap) or the
presentation time of the stimuli (a multiple of 17.7 ms).
Training started with a 41 pixels/53 ms session and
continued until overall performance approached 75% of
correct responses (with 50% being chance level and
100% being perfect performance).
The actual experiment consisted of six blocks of 80
trials each. Each block included the continuous versions
of the 40 stimuli and the deleted versions of one
condition (two blocks with the negative minima dele-
tions, two blocks with the positive maxima deletions,
two blocks with the inflection deletions); the blocks
were presented in random order, with the restriction
that all conditions had to have passed once before a
condition was presented for the second time. There was
a self-terminated pause after each block. The course of
the trials was the same as in the training sessions; the
order of the trials was randomized within each block.
Gap size and presentation duration were set individu-
ally, based on the performance during training, as to
approach an overall performance of 75% correct
responses.
2.5. Apparatus
The experiment was run on an IBM-compatible Fuji
Tech 66 MHz 486 DX2 PC with an SVGA graphics
card, connected to a Sony Trinitron 14 screen. With a
resolution of 800×600 pixels, the refresh rate was 56.6
Hz. The experiment, as well as the training sessions,
were performed monocularly with the dominant eye, as
benzodiazepines are known to disrupt binocular vision
(Giersch, Boucart, Speeg-Schatz, Kauffmann-Muller &
Danion, 1996). Viewing distance was 100 cm; stimuli
measured 5° of visual angle. Testing was performed
in a dimly lit room.
2.6. Analysis
Signal detection measures (d s) were calculated for
each experimental block. These d s are defined as the
z-value of the proportion of hits minus the z-value of
the proportion of false alarms (Macmillan & Creelman,
1991). For each experimental group (placebo, lo-
razepam, diazepam), the d s were subjected to an analy-
sis of variance (ANOVA), with gap condition (negative
minima, positive maxima or inflections) and repetition
Fig. 2. Average d ’ by pharmacological group and gap condition.
condition (first or second presentation) as within-sub-
jects variables (the experiment can be conceived of as
consisting of two halves with in each half one blocked
presentation of each gap condition; see Section 2.4).
The level of significance was set at 0.05.
3. Results
Six subjects were excluded from the analysis because
their overall performance deviated too much from the
norm of 75% of correct responses. These subjects had a
proportion of correct responses below 0.65 (n=4) or
above 0.85 (n=2). Of the remaining subjects, nine were
in the placebo group, six were in the diazepam group
and nine were in the lorazepam group. Mean propor-
tion of correct responses was 0.74 (same proportion
with all subjects included).
For the placebo group, the 3×2 ANOVA on the d s
revealed no significant main effects nor a significant
interaction. Most importantly, gaps were equally de-
tectable in all three gap conditions (inflections: d =
2.11; maxima: d =1.99; minima: d =2.07; see Fig. 2).
For the lorazepam group, there was a marginally
significant effect of gap condition, F(2,16)=3.53, P
0.054. A least significant differences (LSD) test revealed
that gaps at inflections (d =2.10) were significantly
better detected than maxima gaps (d =1.50), while
detection of minima gaps (d =1.74) did not differ
significantly from detection of both inflection and max-
ima gaps (see Fig. 2). The difference between detection
of gaps at inflections and gaps at maxima remained
significant when a more conservative Tukey honest
significant differences (HSD) test was applied instead of
an LSD test. All other effects were non-significant.
For the diazepam group, the pattern of results was
highly parallel to the pattern of results for the placebo
group (see Fig. 2). No significant effects were found;
gaps were equally detectable at inflections (d =1.74),
maxima (d =1.62) and minima (d =1.68).
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As the repetition factor did not have a significant
effect for any of the three groups, the average d s have
been collapsed over both experimental halves in Fig. 2.
Apart from the sensitivity measure (d ), average reac-
tion times were calculated for each participant. Only
trials in which a correct response was given were in-
cluded (74% of the data). Overall, there was a signifi-
cant negative correlation between this measure and a d 
calculated over all blocks (r(24)=−0.44, P0.05).
Thus, the longer the average reaction time of a given
subject, the worse his global signal detection. ANOVAs
per group revealed no significant differences in mean
reaction time between gap conditions.
Finally, visual–analogue scales were used to assess
subjective sedation of the subjects (Bond & Lader,
1974). The scales were rated by the subjects, the first
time prior to drug administration (base-line rating) and
the second time at 09:35 or 10:55 h (depending on the
hour of beginning of testing). From the ratings at each
moment a sedation score was calculated, after which
the base-line score was subtracted from the second
score. This difference score (DS) was then used as an
index of subjective sedation and subjected to an
ANOVA with pharmacological condition as between-
subjects variable. The main effect of pharmacological
group was non-significant. An LSD test revealed a
marginally significant difference in subjective sedation
between placebo group (DS=11.11) on the one hand
and lorazepam group (DS=24.20) and diazepam
group (DS=27.07) on the other hand (P0.085 and
0.062, respectively). The correlation between subjective
sedation and global signal detection (d ) was non-sig-
nificant nor was the correlation between subjective
sedation and average reaction time.
4. Discussion
The results of the experiment can be summarized as
follows. In the placebo group, there are no differences
in detection of gaps at inflections, at positive maxima
or at negative minima. In the lorazepam group, detec-
tion of gaps at inflections is better than detection of
gaps at positive maxima; detection of gaps at negative
minima does not differ from detection of gaps in both
other conditions. In the diazepam group, the pattern of
results is as in the placebo group. Longer overall aver-
age reaction times go together with lower overall signal
detection. Subjective sedation tends to be higher in the
lorazepam and in the diazepam group compared to the
placebo group, though not significantly so. There is no
significant correlation between overall signal detection
and subjective sedation nor between overall average
reaction time and subjective sedation.
Before we go on to interpret these findings, we
should warn against another way of looking at the
data, that, tempting as it may be, is invalid. Looking at
Fig. 2, one might indeed be inclined to make direct
comparisons between the data of the various drug
groups. Such comparisons are by no means allowed. As
outlined in Section 2, the overall level of difficulty of
the experimental task was adjusted for each subject by
adapting gap width and presentation duration, to en-
sure that global performance of each participant (over
all gap conditions) was largely above chance level, but
far from perfect. Only in this way, a priori chances for
the appearance of significant gap detection differences
between gap conditions could be considered to be equal
for the three drug groups. As a consequence though,
the results for the three gap conditions are not indepen-
dent within each group: Better performance in one gap
condition has to go at the cost of performance in one or
both of the other gap conditions. Furthermore, and
most importantly, the individual manipulation of the
objective task difficulty implies that differences between
the three drug groups in global performance are irrele-
vant and may by no means be interpreted, as they are
confounded by the manipulation of the global perfor-
mance level of each individual participant. As a result,
only the pattern of results within each drug group may
be compared between drug groups.
The absence of an effect of gap condition in the
placebo group is as surprising as it is puzzling. Indeed,
a better detection of maxima gaps compared to the
other two conditions was expected. Not only are the
present results hard to reconcile with the results of
Lamote and Wagemans (1999), they are also not in line
with the results of a pilot study (n=7) that we did with
the same paradigm in which gaps at maxima were
significantly better detected than gaps at minima (d =
2.02 and d =1.60, respectively, unpublished data). Any
explanation must remain speculative. It is a fact that, in
general, smaller gaps and shorter stimulus presentations
were needed in the present experiment compared to the
Lamote and Wagemans (1999) experiment in order to
obtain comparable overall percentages of correct re-
sponses. This suggests at least that the task was not
completely the same for our subjects as it was for the
subjects of Lamote and Wagemans (1999). But, it re-
mains unclear what the crucial distinctions were be-
tween the present experiment and the previous ones on
a procedural level. One might have been the addition of
a training phase, in which the various gap conditions
were presented intermixed instead of blocked, as in the
actual experimental phase. Another difference was, of
course, the individual adaptation to the difficulty of the
experimental task in order to guarantee an intermediate
level of correct responses.
Whatever the reason may be, it does not affect
interpretation of the results for the other two groups.
Indeed, as the experimental circumstances were com-
pletely identical for these groups and the placebo
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group, the results for these groups can be interpreted in
comparison with the results of the placebo group.
Compared to the pattern of results for the placebo
group, the results for the lorazepam group are in line
with our expectations. Inflection gaps are indeed rela-
tively easier to detect than in the placebo group, largely
at the cost of detection of maxima gaps. As explained
in Section 1, this result fits in with the disruption of
perceptual integration processes under the influence of
lorazepam, a disruption that should affect mainly
filling-in of straight contour gaps, such as gaps at
inflections.2 As such, this result corroborates earlier
findings in an entirely different paradigm.
More novel is the pattern of results in the diazepam
group. This pattern is identical to the pattern of results
for the placebo group and unlike the pattern of results
for the lorazepam group. In contrast with the lo-
razepam group, gaps at inflections were no easier to
detect than gaps at other curvature singularities in the
diazepam group.
As such, our results can be taken as first evidence
that lorazepam and diazepam differ not only with
respect to their effect on implicit memory functioning,
but also with respect to their effect on perceptual
integration. The conclusion of the present study is that,
at the doses used, diazepam does not impair perceptual
integration, whereas lorazepam does. If the selective
influence of lorazepam on perceptual integration is
further corroborated, this bears important implications
for future pharmacological dissociation research involv-
ing benzodiazepines, because the doses used in the
present study were chosen in accordance with the doses
ordinarily used in pharmacological memory research.
When using lorazepam and diazepam to evaluate the
contribution of implicit memory processes on cognitive
functioning, impairment of perceptual integration may
thus always be an alternative account for possible
differences between lorazepam- and diazepam-treated
subjects. Differentiating between both accounts (the
‘perceptual’ account versus the ‘memory’ account) is
not always obvious, and should be considered
beforehand.
The question why lorazepam and diazepam should
have different effects on perceptual integration remains
to be settled, as both drugs are supposed to enhance
GABAA-mediated inhibition to a comparable extent.
However, recent evidence suggests that both drugs have
a different impact on the frequency characteristics of
GABAA-mediated neuronal activity. Lorazepam seems
to enhance neuronal synchronization, whereas di-
azepam does not and this neuronal synchronization is
supposed to play an important role in the emergence of
perceptual grouping (Elliott, Becker, Boucart, &
Mu¨ller, 2000). This is the only other study that we are
aware of that has shown lorazepam and diazepam to
have different effects on perceptual organization. It
remains to be seen to what extent differences in neu-
ronal synchronization can also be held responsible for
differential influences of lorazepam and diazepam on
low-level perceptual integration. Furthermore, the
molecular mechanisms underlying this neuronal syn-
chronization can only be speculated upon. More re-
search on the effects of benzodiazepines on neural
functioning will thus be needed in order to yield insight
in how and where perceptual integration is occurring.
However, the present research does suggest that a par-
ticularly fruitful strategy might be to look for neuronal
effects that are not common to all benzodiazepines, but
are specific to lorazepam or a yet to be defined sub-
group of benzodiazepines (not including diazepam).
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